Escherichia coli (CAS NO : 68583-22-2)

E. coli expression hosts are increasingly prioritized by American CDMOs for the scalable production of high purity fine chemicals, specifically recombinant proteins and therapeutic enzymes, where optimized metabolic engineering ensures yield consistency in a shifting global sourcing landscape. Coliform bacterial isolates for diagnostic use are undergoing rigorous validation to meet the 2024 FDA Laboratory Developed Tests rule, prompting laboratories to seek custom synthesis services for specialized genomic markers and high-sensitivity PCR reagents that facilitate rapid pathogen identification. This versatile Gram-negative bacterium is further leveraged in the synthetic biology sector for producing bio-based precursors with a 98% industrial-grade purity (bioplastics industry), as a reliable bulk chemical supplier network becomes vital for supporting the domestic transition toward sustainable chemical manufacturing. We are an established Escherichia coli intermediates supplier with >= 99% purity in the united states, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Escherichia coli COA/TDS/SDS region-specific regulatory support, reliable lead times, worldwide supply chain capabilities